Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Common Equity (2016 - 2025)

AtriCure (ATRC) has disclosed Common Equity for 16 consecutive years, with $491.9 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 6.72% to $491.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $491.9 million through Dec 2025, up 6.72% year-over-year, with the annual reading at $491.9 million for FY2025, 6.72% up from the prior year.
  • Common Equity for Q4 2025 was $491.9 million at AtriCure, up from $476.5 million in the prior quarter.
  • The five-year high for Common Equity was $491.9 million in Q4 2025, with the low at $385.1 million in Q2 2021.
  • Average Common Equity over 5 years is $457.7 million, with a median of $462.3 million recorded in 2023.
  • The sharpest move saw Common Equity skyrocketed 72.08% in 2021, then fell 7.81% in 2022.
  • Over 5 years, Common Equity stood at $483.8 million in 2021, then decreased by 5.58% to $456.8 million in 2022, then increased by 2.06% to $466.2 million in 2023, then dropped by 1.12% to $461.0 million in 2024, then rose by 6.72% to $491.9 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $491.9 million, $476.5 million, and $464.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.